Dr. Joykumar Girishbhai Patel, MD

Dr. Patel practices at INTEGRIS Health Baptist Medical Center in Oklahoma City, Oklahoma, part of INTEGRIS Health.

Dr. Patel's NPI, 1730310210, was assigned on August 2, 2009. Dr. Patel holds Oklahoma license 27793.

Dr. Patel's primary practice is INTEGRIS Health Baptist Medical Center, at 3300 Northwest Expressway, Oklahoma City, OK 73112 in Oklahoma County. The practice phone is (405) 949-3011.

Dr. Patel's primary practice is INTEGRIS Health Baptist Medical Center in Oklahoma City, Oklahoma, part of INTEGRIS Health. Dr. Patel is also affiliated with INTEGRIS Health Southwest Medical Center. The medical group on file is INTEGRIS Health Nazih Zuhdi Transplant Institute. Dmand AI also links Dr. Patel to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 5 sites in all. Vendor and product names are available with a free account.

Hepatology is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dr. Patel is licensed in Oklahoma.

CMS data shows 653 Medicare services from Dr. Patel across 6 procedure codes in 2024, for 387 Medicare patients. Medicare paid $58,913 for them.

CMS counts 387 Medicare patients who saw Dr. Patel in 2024. The largest group is 65 to 74, with 223 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 62, with 50% women.

In 2024, Dr. Patel wrote 2,998 Medicare Part D claims for 327 patients. 85% of them were for generic drugs. CMS names the drug for 2,872 of them, across 42 drugs with 11 or more claims each, at $884,695 in total drug cost. In 2023, CMS named 2,226 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Patel for performance year 2024, reported as part of a group. Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Patel as offering telehealth.

Dmand AI links Dr. Patel to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Hepatitis C, Non-alcoholic Fatty Liver Disease and Fatty Liver.

CMS Open Payments shows 841 general payments to Dr. Patel from 17 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Gilead Sciences, Inc. paid the most, $184,927.